Navigation Links
International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
Date:5/9/2008

WASHINGTON, May 9 /PRNewswire/ -- The International Center for Adult Stem Cell Education (http://www.Adultstemcelleducation.com) today announced that it has officially launched a global communications and government-political affairs program at the 3rd International Spinal Cord Injury Symposium, Olfactory Mucosa Autografts (OMA) and Rehabilitation to be held today, May 9th, through May 10th in Argostolli, Kefalonia, Greece. The ICASCE will be headquartered in Fort Worth, Texas, with operational offices in Washington, D.C. (contact: Jack Wynn, 703-623-4288; jackwynn@comcast.net) and Bangkok, Thailand.

Donald Margolis, ICASCE Chairman and Founder (donmargolis@gmail.com; 215-764-6312), will be one of the guest speakers at the symposium. In 2003, Mr. Margolis became the FIRST person in the world to create a company to treat dying heart patients with adult stem cells. The guest of honor at the symposium will be pioneer Portuguese neuropathologist Dr. Carlos Lima, who has developed the successful OMA transplant surgical procedure for treating spinal cord injury by harvesting patients' own stem cells from their noses, by which those cells are then transplanted into the sites of the spinal cord breaks. ICASCE is a public affairs educational organization seeking to educate and inform the world about the research and treatment of diseases using adult stem cells.

According to Mr. Margolis, "ICASCE was recently (April '08) founded to educate the American public on the potential of adult stem cells for diagnosing, treating, curing and preventing disease. Thousands of people are dying unnecessarily each month because they don't know there are adult stem cell treatments available. The fact is that adult stem cells offer promising prospects for effective treatments and possible cures for people with heart conditions, spinal cord injuries, and a host of incapacitating diseases such as diabetes, Alzheimer's and Parkinson's."


'/>"/>
SOURCE International Center for Adult Stem Cell Education
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
2. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
3. Mindray Medical International Announces First Quarter 2008 Results
4. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
5. MINRAD International, Inc. Announces $40.0 Million Private Placement
6. Statement from Lighthouse International About the Study on Gene Therapy Concerning Lebers Congenital Amaurosis
7. Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
8. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
9. AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
10. PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing
11. International Council on Nanotechnology launches global research needs assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):